TrialCancer medicine2021

Trifluridine/tipiracil plus bevacizumab as a first-line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial.

Eiji Oki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.